DNA Layer editorial and evidence standards

Who publishes the content

DNA Layer is the publisher. Our public pages use an organizational byline because we do not currently claim that every page was written or independently reviewed by a licensed clinician. If a qualified external reviewer assesses a page in the future, that page will name the person, credentials, scope, and review date. Company and contact details are on the About page.

How a page is researched

We begin with a real reader task, then check whether an existing page already owns the answer. Material health and genetics claims should lead to primary evidence: public health agencies and regulators, clinical guidelines and databases, original peer-reviewed research, or official provider documentation. Search results and other summaries can help locate evidence, but they are not treated as the evidence itself.

Product claims are checked against the live DNA Layer experience and its implemented data flow. Examples and screenshots must be representative and non-customer-derived; private DNA files, reports, and personal information are never used as public content.

How software and AI assistance are used

Research organization and drafting may use software or AI assistance. Automation is not an author, medical reviewer, or source. Before publication, factual claims are checked against the linked evidence, product behavior is checked against the live implementation, and unsupported statistics, invented credentials, and keyword-only pages are rejected. The purpose is to help a reader complete a task, not to manufacture search volume.

Health and genetics language

Pages must distinguish association, predisposition, screening, diagnosis, and treatment. A consumer DNA result is one part of a larger clinical picture: providers can test different variants, important variants may be absent, and ancestry, environment, lifestyle, and other genetic factors can change interpretation. The FDA advises that direct-to-consumer results should not be the sole basis for medical decisions. Important findings may require confirmation in a clinical laboratory and discussion with a qualified healthcare professional.

Comparisons and conflicts

DNA Layer is a commercial service and may appear in comparisons that it publishes. Those pages must disclose that conflict, link the source behind each material claim, state what was and was not tested, and avoid affiliate rankings or unsupported winner labels. Published privacy commitments are described as commitments, not as proof of an independent security audit.

Dates, updates, and corrections

A review date changes only after a substantive source or product check. We update or remove claims when the evidence, provider documentation, or product behavior changes. To request a correction, email contact@dnalayer.ai with the page URL, disputed statement, and supporting source. Corrections are evaluated against the same evidence rules; we do not promise that every requested wording change will be accepted.

Sources informing this policy

• Google Search Central: creating helpful, reliable, people-first content
• FDA: direct-to-consumer tests and their limitations
• NHGRI: direct-to-consumer genetic testing FAQ for healthcare professionals
• DNA Layer report methodology and safety floor
• DNA Layer data-flow and privacy guide